Bull case
NOC would need investors to value it at roughly 46x earnings — about 26x more generous than today's 20x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where NOC stock could go
NOC would need investors to value it at roughly 46x earnings — about 26x more generous than today's 20x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
This is close to how the market is already pricing NOC — at roughly 22x forward earnings. No dramatic re-rating needed, just steady execution on the core business.
If investor confidence fades or macro conditions deteriorate, a 6x multiple contraction could push NOC down roughly 29% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Northrop Grumman is a major aerospace and defense contractor that designs, develops, and manufactures advanced military aircraft, space systems, and defense technologies. It generates revenue primarily through long-term government contracts across four segments: Aeronautics Systems (~30%), Defense Systems (~20%), Mission Systems (~25%), and Space Systems (~25%). The company's moat lies in its deep expertise in classified defense programs, complex systems integration capabilities, and entrenched relationships with the U.S. Department of Defense and intelligence agencies.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $7.11/$6.92 | +2.7% | $10.4B/$10.1B | +2.9% |
| Q4 2025 | $7.67/$6.44 | +19.1% | $10.4B/$10.7B | -2.7% |
| Q1 2026 | $7.23/$6.98 | +3.6% | $11.7B/$11.6B | +0.8% |
| Q2 2026 | $6.14/$6.06 | +1.3% | $9.9B/$9.8B | +1.3% |
NOC beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $535 — implies -5.8% from today's price.
| Metric | NOC | S&P 500 | Industrials | 5Y Avg NOC |
|---|---|---|---|---|
| Forward PE | 20.0x | 19.1x | 20.7x | — |
| Trailing PE | 19.2x | 25.1x-23% | 25.7x-25% | 19.4x |
| PEG Ratio | 2.17x | 1.72x+26% | 1.64x+32% | — |
| EV/EBITDA | 16.5x | 15.2x | 13.7x+21% | 17.0x |
| Price/FCF | 24.0x | 21.1x+14% | 21.2x+13% | 34.4x-30% |
| Price/Sales | 1.9x | 3.1x-40% | 1.6x+19% | 1.9x |
| Dividend Yield | 1.61% | 1.87% | 1.27% | 1.54% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolNOC 10.2% ROIC signals a durable competitive advantage — returns 3.7% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~4.6 years to full repayment at current FCF run-rate
* Elevated by buyback-compressed equity — compare ROIC (10.2%) for an undistorted picture of capital efficiency.
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt). ROE marked * where buyback-compressed equity base may inflate the figure.
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 11, 2026
Northrop Grumman’s revenue and cash flow are tightly linked to global security spending. Political instability, U.S. debt ceiling debates, and potential government shutdowns can delay or reduce defense appropriations, directly impacting contract volumes. The company’s exposure to these macro‑economic uncertainties makes this a top risk.
The firm faces a high concentration of litigation and regulatory scrutiny across multiple jurisdictions. Pending lawsuits, compliance investigations, and evolving defense procurement regulations could result in significant penalties, delays, or loss of contracts. These legal exposures pose a substantial threat to profitability.
Northrop Grumman’s complex aerospace projects are susceptible to cost overruns and schedule delays. Losses were recorded under the B‑21 program due to overruns, illustrating the financial impact of operational setbacks. Continued overruns could erode margins and strain cash reserves.
The company relies on estimates for contract accounting, and changes in estimated revenues or costs can materially affect earnings. The inherent complexity of large defense contracts makes accurate forecasting difficult, exposing Northrop Grumman to volatility in reported profitability.
Shifts in U.S. defense budgets and priorities, driven by evolving geopolitical landscapes, can alter funding allocations for Northrop Grumman’s programs. Reduced appropriations or re‑prioritization of defense spending could shrink the company’s order book and revenue base.
In the past three months, insiders have sold more shares than they purchased, potentially signaling management’s lack of confidence. While the volume is not disclosed, such activity may influence investor sentiment and liquidity.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 11, 2026
Northrop Grumman’s backlog stands at $95.7 billion, providing a clear and predictable revenue stream for the coming years. This level of backlog reflects a robust pipeline of defense contracts and underpins the company’s long‑term growth prospects.
The company secured an extension of the Navy SEWIP Block 3 electronic warfare contract, adding a significant, high‑value revenue source to its portfolio. This extension signals continued confidence from the U.S. Navy and strengthens Northrop’s defense market position.
Northrop’s transition to production of the B‑21 bomber is viewed as a major growth driver, with the company positioned as a near‑monopoly in this program. The B‑21’s entry into service is expected to generate substantial, recurring revenue for the firm.
Northrop’s strong backlog, key contract wins, and near‑monopoly on the B‑21 bomber solidify its strategic position within the defense sector. These factors collectively provide visibility for predictable, long‑term growth.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
NOC NOC Northrop Grumman Corporation | $79.3B | 20.0x | +3.4% | 10.8% | Buy | +30.9% |
LMT LMT Lockheed Martin Corporation | $117.3B | 17.0x | +5.1% | 6.4% | Buy | +24.8% |
RTX RTX RTX Corporation | $232.8B | 25.0x | +7.0% | 8.0% | Buy | +30.1% |
GD GD General Dynamics Corporation | $94.4B | 21.2x | +6.1% | 8.1% | Buy | +17.1% |
BA BA The Boeing Company | $176.9B | 4835.8x | +14.0% | 2.5% | Buy | +17.5% |
HII HII Huntington Ingalls Industries, Inc. | $12.8B | 18.8x | +5.9% | 4.7% | Hold | +28.8% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
NOC returns 3.7% annually — 1.61% through dividends and 2.0% through buybacks.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $2.31 | — | — | — |
| 2025 | $8.99 | +11.7% | 2.0% | 3.6% |
| 2024 | $8.05 | +9.7% | 3.6% | 5.4% |
| 2023 | $7.34 | +8.6% | 2.1% | 3.7% |
| 2022 | $6.76 | +9.7% | 1.8% | 3.0% |
Common questions answered from live analyst data and company financials.
Northrop Grumman Corporation (NOC) is rated Buy by Wall Street analysts as of 2026. Of 35 analysts covering the stock, 20 rate it Buy or Strong Buy, 14 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $731, implying +30.9% from the current price of $559. The bear case scenario is $398 and the bull case is $1284.
The Wall Street consensus price target for NOC is $731 based on 35 analyst estimates. The high-end target is $815 (+45.9% from today), and the low-end target is $623 (+11.5%). The base case model target is $625.
NOC trades at 20.0x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals slightly overvalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for NOC in 2026 are: (1) Geopolitical & Macroeconomic Environment — Northrop Grumman’s revenue and cash flow are tightly linked to global security spending. (2) Legal & Regulatory Issues — The firm faces a high concentration of litigation and regulatory scrutiny across multiple jurisdictions. (3) Production & Operational Risks — Northrop Grumman’s complex aerospace projects are susceptible to cost overruns and schedule delays. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates NOC will report consensus revenue of $43.8B (+3.4% year-over-year) and EPS of $30.37 (-5.4% year-over-year) for the upcoming fiscal year. The following year, analysts project $45.8B in revenue.
A confirmed upcoming earnings date for NOC is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
Northrop Grumman Corporation (NOC) generated $3.3B in free cash flow over the trailing twelve months — a free cash flow margin of 7.8%. NOC returns capital to shareholders through dividends (1.6% yield) and share repurchases ($1.6B TTM).